R&D Systems Inc. Tocris Bioscience Boston Biochem

L-371,257

Cat. No. 2410

L-371,257 C28H33N3O6 [162042-44-6]

Price and Availability

For L-371,257 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: 1-[4-[(1-Acetyl-4-piperidinyl)oxy]-­2-methoxybenzoyl]-4-(2-oxo-2H-3,1-benzoxazin-1(4H)­-yl)piperidine

Biological Activity

Potent, high affinity human oxytocin (OT) receptor antagonist (Ki = 4.6 nM) that displays > 800-fold selectivity over human arginine vasopressin receptors V1a and V2. Antagonizes oxytocin-induced contractions in isolated rat uterine tissue (pA2 = 8.44) and in anesthetised rats following intravenous and intraduodenal administration. Orally active.

Technical Data

M.Wt:
507.59
Formula:
C28H33N3O6
Solubility:
Soluble to 10 mM in DMSO with gentle warming
Purity:
>99 %
Storage:
Store at RT
CAS No:
162042-44-6

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet

References

Williams et al (1995) 1-{1-[4-[N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4-yl}-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist. J.Med.Chem. 38 4634. PMID: 7473590.

Tahara et al (1999) Comparison of vasopressin binding sites in human uterine and vascular smooth muscle cells. Eur.J.Pharmacol. 378 137. PMID: 10478574.

Tahara et al (2000) Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells. Br.J.Pharmacol. 129 131. PMID: 10694212.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Keywords: L-371,257, supplier, Potent, selective, oxytocin, receptors, antagonists, OT, Receptors, L371257

Quick Order

Find multiple products by catalog number

divider line

7-TM Receptor Signaling

Written by T. Kenakin et al

7-TM Poster

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

New Products in this Area

Carbetocin

Oxytocin analog

ML 221

Apelin receptor (APJ) antagonist

Q94 hydrochloride

Negative allosteric modulator at PAR1 receptor

FSLLRY-NH2

PAR2 peptide antagonist

SB 611812

Urotensin-II (UT) antagonist; attenuates cardiac dysfunction

TC-MCH 7c

Selective melanin-concentrating hormone receptor 1 (MCH1R) antagonist

CYM 9484

Potent NPY Y2 receptor antagonist

Sign-up for new product e-alerts
divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions